Psychosis in Parkinson's Disease: Case Studies

Brian Salter, Karen E. Anderson, William J. Weiner

Research output: Contribution to journal › Review article

Abstract

Psychosis is common in patients who have PD and leads to significant disability. Patients often can be managed with nonpharmacologic interventions or with decreasing doses of antiparkinsonism medications. If these interventions are insufficient, then atypical antipsychotics should be considered. Clozapine is used in more refractory cases and requires stringent monitoring for agranulocytosis.

Original languageEnglish (US)
Pages (from-to)363-369
Number of pages7
JournalNeurologic Clinics
Volume24
Issue number2
DOIs
StatePublished - May 1 2006
Externally publishedYes

Fingerprint

Psychotic Disorders
Parkinson Disease
Agranulocytosis
Clozapine
Antipsychotic Agents

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Psychosis in Parkinson's Disease : Case Studies. / Salter, Brian; Anderson, Karen E.; Weiner, William J.

In: Neurologic Clinics, Vol. 24, No. 2, 01.05.2006, p. 363-369.

Research output: Contribution to journal › Review article

Salter, B, Anderson, KE & Weiner, WJ 2006, 'Psychosis in Parkinson's Disease: Case Studies', Neurologic Clinics, vol. 24, no. 2, pp. 363-369. https://doi.org/10.1016/j.ncl.2006.01.003
Salter B, Anderson KE, Weiner WJ. Psychosis in Parkinson's Disease: Case Studies. Neurologic Clinics. 2006 May 1;24(2):363-369. https://doi.org/10.1016/j.ncl.2006.01.003
Salter, Brian ; Anderson, Karen E. ; Weiner, William J. / Psychosis in Parkinson's Disease : Case Studies. In: Neurologic Clinics. 2006 ; Vol. 24, No. 2. pp. 363-369.
@article{eebacd6495444a969319156e4d823708,
title = "Psychosis in Parkinson's Disease: Case Studies",
abstract = "Psychosis is common in patients who have PD and leads to significant disability. Patients often can be managed with nonpharmacologic interventions or with decreasing doses of antiparkinsonism medications. If these interventions are insufficient, then atypical antipsychotics should be considered. Clozapine is used in more refractory cases and requires stringent monitoring for agranulocytosis.",
author = "Brian Salter and Anderson, {Karen E.} and Weiner, {William J.}",
year = "2006",
month = "5",
day = "1",
doi = "10.1016/j.ncl.2006.01.003",
language = "English (US)",
volume = "24",
pages = "363--369",
journal = "Neurologic Clinics",
issn = "0733-8619",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Psychosis in Parkinson's Disease

T2 - Case Studies

AU - Salter, Brian

AU - Anderson, Karen E.

AU - Weiner, William J.

PY - 2006/5/1

Y1 - 2006/5/1

N2 - Psychosis is common in patients who have PD and leads to significant disability. Patients often can be managed with nonpharmacologic interventions or with decreasing doses of antiparkinsonism medications. If these interventions are insufficient, then atypical antipsychotics should be considered. Clozapine is used in more refractory cases and requires stringent monitoring for agranulocytosis.

AB - Psychosis is common in patients who have PD and leads to significant disability. Patients often can be managed with nonpharmacologic interventions or with decreasing doses of antiparkinsonism medications. If these interventions are insufficient, then atypical antipsychotics should be considered. Clozapine is used in more refractory cases and requires stringent monitoring for agranulocytosis.

UR - http://www.scopus.com/inward/record.url?scp=33646202314&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646202314&partnerID=8YFLogxK

U2 - 10.1016/j.ncl.2006.01.003

DO - 10.1016/j.ncl.2006.01.003

M3 - Review article

C2 - 16684637

AN - SCOPUS:33646202314

VL - 24

SP - 363

EP - 369

JO - Neurologic Clinics

JF - Neurologic Clinics

SN - 0733-8619

IS - 2

ER -

Access to Document